Andrew Menzies‐Gow
- Immunology and Allergy top 0.2%
- Allergic Rhinitis and Sensitization 37
- Physiology top 0.1%
- Asthma and respiratory diseases 166
- Pulmonary and Respiratory Medicine top 0.2%
- Respiratory and Cough-Related Research 76
- Inhalation and Respiratory Drug Delivery 34
- Chronic Obstructive Pulmonary Disease (COPD) Research 23
- Immunology top 1%
- IL-33, ST2, and ILC Pathways 24
- Emergency Medical Services top 0.5%
-
- Eosinophilic Esophagitis 31
-
- Pharmaceutical studies and practices 13
- Co-authors
- Douglas S. RobinsonA B KayPatrick Flood-PageChristopher E. BrightlingLiam G. HeaneyAdel MansurClaire McBrienRobert Niven
- Journals
- New England Journal of Medicine (1 paper)The Lancet (1 paper)Journal of Clinical Investigation (2 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Andrew Menzies‐Gow
171 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Immunology and Allergy 1.7k
- Physiology 6.6k
- Pulmonary and Respiratory Medicine 4.5k
- Immunology 1.8k
- Emergency Medical Services 509
Countries citing papers authored by Andrew Menzies‐Gow
This map shows the geographic impact of Andrew Menzies‐Gow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Menzies‐Gow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Menzies‐Gow more than expected).
Fields of papers citing papers by Andrew Menzies‐Gow
This network shows the impact of papers produced by Andrew Menzies‐Gow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Menzies‐Gow. The network helps show where Andrew Menzies‐Gow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Menzies‐Gow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 24 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 7 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 30 | |
| 11 | 2020 | 75 | |
| 12 | 2019 | 1 | |
| 13 | 2019 | 219 | |
| 14 | 2018 | 1 | |
| 15 | 2018 | 23 | |
| 16 | 2014 | 134 | |
| 17 | 2013 | 1 | |
| 18 | 2003 | 59 | |
| 19 | Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmaticsbreakdown → | 2003 | 645 |
| 20 | Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airwaybreakdown → | 2003 | 632 |
About Andrew Menzies‐Gow
Andrew Menzies‐Gow is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 189 papers that have together received 7.9k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (166 papers), Respiratory and Cough-Related Research (76 papers), Allergic Rhinitis and Sensitization (37 papers), Inhalation and Respiratory Drug Delivery (34 papers), Eosinophilic Esophagitis (31 papers), IL-33, ST2, and ILC Pathways (24 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (23 papers) and Pharmaceutical studies and practices (13 papers). The work is most often cited by research in Immunology and Allergy (1.7k citations), Physiology (6.6k citations) and Pulmonary and Respiratory Medicine (4.5k citations). Andrew Menzies‐Gow has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Douglas S. Robinson, A B Kay, Patrick Flood-Page, Christopher E. Brightling, Liam G. Heaney, Adel Mansur, Claire McBrien, Robert Niven, Simon Phipps and Celeste Porsbjerg. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.